AI assistant
Sending…
PETMED EXPRESS INC — Director's Dealing 2020
Apr 17, 2020
34556_dirs_2020-04-17_29fac4cc-6923-4024-8c06-503db8f6e028.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PETMED EXPRESS INC (PETS)
CIK: 0001040130
Period of Report: 2020-04-16
Reporting Person: ROSENBLOOM BRUCE S (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-16 | Common Stock | S | 3500 | $32.50 | Disposed | 38384 | Direct |
Footnotes
F1: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy.
More from PETMED EXPRESS INC
Annual Report
2026
Jun 2
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
Feb 11
Interim / Quarterly Report
2026
Feb 5
Regulatory Filings
2026
Jan 23
Director's Dealing
2026
Jan 23
Interim / Quarterly Report
2025
Dec 19
Interim / Quarterly Report
2025
Dec 19
Major Shareholding Notification
2025
Dec 11